Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/283483 
Year of Publication: 
2023
Series/Report no.: 
Documento de investigación No. 186
Publisher: 
South Centre, Geneva
Abstract (Translated): 
This research paper aims to identify, describe and analyze the patents on monoclonal antibodies granted by the National Institute of Industrial Property (INPI) of Argentina, from 2010 to 2020 inclusive. The research includes the protected subject matter and the universe of applicants, among other aspects. To this end, a database of patents and applications was created, where the characteristics of the patent applications and granted patents, ownership and nationality of the applicants, status of the applications, the time it takes to process a patent application and divisional patents are examined. The document also presents recommendations on public policy applicable to the examination of patent applications on monoclonal antibodies.
Subjects: 
Access to Medicines
Argentina
Biologicals
Biologics
Biopharmaceuticals
Biosimilars
Intellectual Property
Monoclonal Antibodies
Patent
Public Health
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.